Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[1998 malaria therapy]

K Markwalder1, C Hatz

  • 1Konsiliarius für Tropenmedizin, Departement Innere Medizin, Universitätsspital Zürich.

Schweizerische Medizinische Wochenschrift
|October 24, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-term immunogenicity after yellow fever vaccination in immunosuppressed and healthy individuals.

Vaccine·2020
Same author

Ethnicity predicts viral rebound after travel to the tropics in HIV-infected travelers to the tropics in the Swiss HIV Cohort Study.

HIV medicine·2017
Same author

Estimating healthcare costs of acute gastroenteritis and human campylobacteriosis in Switzerland.

Epidemiology and infection·2016
Same author

Ultrasound assessment of schistosomiasis.

Zeitschrift fur Gastroenterologie·2016
Same author

Predominance of dfrG as determinant of trimethoprim resistance in imported Staphylococcus aureus.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2015
Same author

Travel style is a major risk factor for diarrhoea in India: a prospective cohort study.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2015
Same journal

Respiratory function test in the case of temporary phrenic nerve contusion, associated with pneumoperitoneum; About the diagnostic value of laparoscopy.

Schweizerische medizinische Wochenschrift·2010
Same journal

Treatment of pulmonary tuberculosis and pleurisy by means of temporary paralysis of the diaphragm, supported by the pneumoperitoneum.

Schweizerische medizinische Wochenschrift·2010
Same journal

Boeck's disease as a tuberculous syndrome.

Schweizerische medizinische Wochenschrift·2010
Same journal

Enteral primary tubercular complexes

Schweizerische medizinische Wochenschrift·2010
Same journal

Tuberculous stenoses of the large bronchi.

Schweizerische medizinische Wochenschrift·2010
Same journal

About the enzyme action.

Schweizerische medizinische Wochenschrift·2010
See all related articles

For malaria treatment in Switzerland, mefloquine is recommended for uncomplicated Plasmodium falciparum malaria due to widespread chloroquine resistance. Severe cases or high parasitaemia require quinine, with hospitalization advised for uncertain prognoses.

Area of Science:

  • Tropical Medicine
  • Pharmacology

Context:

  • Switzerland faces imported malaria cases, predominantly Plasmodium falciparum.
  • High prevalence of chloroquine-resistant malaria in common travel destinations poses a challenge.

Purpose:

  • To provide evidence-based recommendations for malaria treatment tailored to Switzerland.
  • To guide clinicians in selecting appropriate antimalarial drugs based on resistance patterns and patient factors.

Summary:

  • Mefloquine is the first-line treatment for uncomplicated Plasmodium falciparum malaria imported into Switzerland, given prevalent chloroquine resistance.
  • Quinine is the preferred drug for severe malaria or parasitaemia exceeding 2%.
  • Treatment decisions must weigh drug resistance, clinical status, intolerance, and drug interactions. Hospitalization is recommended for uncertain cases, with consideration for ancillary treatments like exchange transfusion.

Related Experiment Videos

Impact:

  • Optimized malaria treatment protocols for the Swiss context.
  • Improved patient outcomes by addressing drug resistance and severe malaria management.
  • Informed clinical decision-making for healthcare professionals treating imported malaria.